Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (1843)	10/17/2000 8:37:56 AM
From: tom pope	Read Replies (1) \| Respond to of 52153

CIST may be an interesting arbitrage. It currently trades (if 90k shares of a penny stock qualifies as trading) around 60 cents. CLL has an agreement, which will be voted on by CIST shareholders on Nov 2, to purchase CIST for .01978 shares of CLL. Based on CLL's closing price 10/16 of 38 1/2, that would make CIST shares worth 76 cents. So far as I can tell, there are no current roadblocks to the completion of the merger. If that's a correct assessment, the discount seems a bit steep. FWIW. I bought some yesterday at 60 cents.